Select Clinical Trial
Venous Thromboembolism - Cancer Related
RU221501I: A Phase III, Randomized, Open Label Study Evaluating the Safety of Apixaban in Subjects With Cancer Related Venous Thromboembolism
- Men and women, ages 18 and older, with confirmed acute lower extremity or upper extremity with venous thrombosis in addition to cancer of any type with the exception of non-melanoma skin cancer. For more information, please contact the study coordinator at 910-715-2200.